Two diets lowered a measured aging score in MS studies

Credibility

Interest

Share:1 min read

Key Takeaway

A modified ketogenic diet and intermittent calorie restriction each lowered an aging score in people with MS.

What They Found

Researchers looked again at results from two earlier diet studies. After six months on a modified ketogenic diet, participants had a lower score that estimates aging from substances in the body. The score also fell after eight weeks of intermittent calorie restriction, or cutting calories at intervals. Daily calorie restriction did not lower the score. The abstract does not report whether any diet changed MS symptoms or disability.

Who Should Care and Why

The studies included people with MS. One study followed people on a modified ketogenic diet, which limits carbohydrates. The other compared intermittent calorie restriction, daily calorie restriction, and a diet meant to keep weight steady. The finding concerns an aging score, not a measured change in how people felt or functioned. The abstract does not name the forms of MS the participants had.

Important Considerations

You are seeing a second look at two earlier diet studies involving 75 people in total. One study lasted six months; the other lasted eight weeks and assigned participants to different diets at random. You cannot tell from this abstract whether a lower aging score led to better health.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Nutrition Early Research

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Annals of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News